Bain, J. ., Prendergast, M. ., AV, T. . , Jr, Arneric, S. ., Smith, M. ., & Buccafusco, J. . (2003). Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential. Psychopharmacology, 169(2), 150-60. https://doi.org/10.1007/s00213-003-1483-1

Prendergast, M. ., Jackson, W. ., AV, T. . , Jr, Kille, N. ., Arneric, S. ., Decker, M. ., & Buccafusco, J. . (1998). Age-related differences in distractibility and response to methylphenidate in monkeys. Cerebral Cortex (New York, N.Y. : 1991), 8(2), 164-72. https://doi.org/10.1093/cercor/8.2.164

Prendergast, M. ., Jackson, W. ., AV, T. . , Jr, Decker, M. ., Arneric, S. ., & Buccafusco, J. . (1998). Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys. Psychopharmacology, 136(1), 50-8. https://doi.org/10.1007/s002130050538

Decker, M. ., Bannon, A. ., Curzon, P. ., Gunther, K. ., Brioni, J. ., Holladay, M. ., … Arneric, S. . (1997). ABT-089 2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride : II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys. The Journal of Pharmacology and Experimental Therapeutics, 283(1), 247-58. Retrieved from https://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=9336330

Briggs, C. ., Anderson, D. ., Brioni, J. ., Buccafusco, J. ., Buckley, M. ., Campbell, J. ., … Arneric, S. . (1969). Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacology, Biochemistry, and Behavior, 57(1-2), 231-41. https://doi.org/10.1016/s0091-3057(96)00354-1 (Original work published 1969)

Prendergast, M. ., AV, T. . , Jr, Jackson, W. ., Marsh, K. ., Decker, M. ., Arneric, S. ., & Buccafusco, J. . (1997). Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418. Psychopharmacology, 130(3), 276-84. https://doi.org/10.1007/s002130050240

Lin, N. ., Gunn, D. ., Ryther, K. ., Garvey, D. ., Donnelly-Roberts, D. ., Decker, M. ., … Holladay, M. . (1997). Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties. Journal of Medicinal Chemistry, 40(3), 385-90. https://doi.org/10.1021/jm960233u (Original work published 1997)